# Filing Detail

Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001140361-24-022725
Filing Date
2024-04-29
Accepted
2024-04-29 08:49:16
Documents
1
Period of Report
2023-12-31
Effectiveness Date
2024-04-29

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | ARS | ny20022295x4_ars.pdf | ARS | 1428346
| Complete submission text file | 0001140361-24-022725.txt |  | 1968924

Mailing Address 12770 HIGH BLUFF DRIVE, SUITE 150 SAN DIEGO CA 92130
Business Address 12770 HIGH BLUFF DRIVE, SUITE 150 SAN DIEGO CA 92130 (619) 949-3681
GYRE THERAPEUTICS, INC. (Filer) CIK: 0001124105 (see all company filings)

EIN.: 562020050 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 000-51173 | Film No.: 24886870
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)